SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63324 355 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
63043SRPT is still over 10% of my portfolio. Less so than before due to the price drstockdoc7710March 20
63042Cantor Fitzgerald analyst Kristen Kluska reiterates Sarepta Therapeutics(SRPT) wluckydog881March 19
63041Couple more analysts this morning: Deutsche Bank analyst David Hoang maintains luckydog88-March 19
63040Needham analyst Gil Blum reiterates Sarepta Therapeutics(SRPT) with a Buy and maluckydog882March 18
63039I want more information, but this appears to be a likely opportunity to pick up Olecranon1March 18
63038Picked some more up since this seems to be a one offerippetoe-March 18
63037SRPT: investorrelations.sarepta.com Unfortunately true, a patient died due to aerickerickson1March 18
63036Sarepta down 18% in pre-market. Rumor is patient death from a dear doctor letteraudioWCAG2.11March 18
63035Biolata EpCAM is overexpressed in a wide range of tumors, making it an ideaforgetme-March 16
63034Biolata EpCAM is overexpressed in a wide range of tumors, making it an ideaforgetme-March 16
63033biolata Tce program will have data at asco. Co has disclosed mtd has not been reforgetme-March 16
63032No one here paying attention? investors.meiragtx.comaudioWCAG2.1-March 13
63031Bluebird. finance.yahoo.comsysiphus-March 13
63030ir.bioatla.com stock collapsed because partnership did not materializeforgetme-March 10
63029abby400 different target and toxin with different linker ascopubs.org meetings.aforgetme-March 8
63028ctmx currently at dose 7th active dose started at level 3 according to ceo fromforgetme1March 7
63027For holders of AUPH see news below: finance.yahoo.complhky34651March 7
63026Good to see this board still going strong. Top two biotech positions right nowaudioWCAG2.11March 7
63025AADI gurufocus.comsysiphus2March 6
63024just an update on SRPT: While the market is weak in general, and XBI has goneluckydog881March 4
63023re: Joining the SAVA lawsuit. Daddy: I have the exact same reaction to these aerickerickson3February 28
63022re: SRPT target prices: <insert rant I've made ad-nauseam about financiaerickerickson-February 28
63021Management guided revenues of about 3 billion for 2025. Market cap is only 10 bstockdoc774February 27
63020For those SRPT followers: Earning were released last night, seemed largely withluckydog881February 27
63019Am out. Can’t wait till 2027. Taking the hit and moving on.dorightbythem-February 26
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News